Comparison of two systemic steroid regimens for the treatment of COPD exacerbations


ÇEVİKER Y., SAYINER A.

PULMONARY PHARMACOLOGY & THERAPEUTICS, cilt.27, ss.179-183, 2014

  • Cilt numarası: 27 Konu: 2
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1016/j.pupt.2013.03.004
  • Dergi Adı: PULMONARY PHARMACOLOGY & THERAPEUTICS
  • Sayfa Sayısı: ss.179-183

Özet

Rationale: Systemic steroids shorten recovery time, improve lung function and hypoxemia in COPD exacerbations. Although several studies have shown that both parenteral and oral steroids are effective and GOLD guideline recommends use of oral steroids at a dose of 30-40 mg/day, very little data exists as to whether any route of admininstration (parenteral vs oral) or any dose is more effective and/or safer.